Metaclazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401536This classification denotes a benzodiazepine with the molecular formula C18H18BrClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C2N2B1303L, chemically known as 7-bromo-5-(o-chlorophenyl)-2,3-dihydro-2-(methoxymethyl)-1-methyl-1h-1,4-benzodiazepine but generally known as metaclazepam, which bears US NIH Compound Identifier 71272. European Medicines Agency schedules Metaclazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08800MIG. The term METACLAZEPAM is an International Non-Proprietary Name. METACLAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metaclazepam under HS 29339940 and SITC 51577. As of Q4 2014, METACLAZEPAM remains the US FDA Preferred Term for this commodity. Metaclazepam bears US NLM identifiers UMLS ID C1619621 and NCI Concept Code C83941. SMILES: BRC1CC2C(N(C(CN=C2C2C(CL)CCCC2)COC)C)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.